Paper6443576
Advanced prostatic adenocarcinoma: biological aspects and effects of androgen deprivation achieved by castration or agonistic analogues of LHRH.
Tolis G and 5 others. Med Oncol Tumor Pharmacother, 1984. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Advanced prostatic adenocarcinoma: biological aspects and effects of androgen deprivation achieved by castration or agonistic analogues of LHRH. Papers, record 6443576. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6443576
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Advanced prostatic adenocarcinoma: biological aspects and effects of androgen deprivation achieved by castration or agonistic analogues of LHRH.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Buserelin | Major topic |
| Orchiectomy | Major topic |
| Prostatic Neoplasms | Major topic |
| Acid Phosphatase | |
| Alkaline Phosphatase | |
| Bone and Bones | |
| Hormones | |
| Humans | |
| Male | |
| Neoplasm Staging | |
| Prostate | |
| Radiography | |
| Receptors, Androgen | |
| Ultrasonography |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6800852 | Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men. | Fertil Steril | 1982 | https://conductscience.org/library/papers/6800852 | PubMed |
| 2 | 6415631 | Transabdominal ultrasonography in the evaluation of patients with advanced prostatic carcinoma: effects of castration and of chronic administration of a gonadotropin releasing hormone agonistic analogue. | Prostate | 1983 | https://conductscience.org/library/papers/6415631 | PubMed |
| 3 | 442131 | A microassay for the measurement of androgen receptors in human prostatic tissue. | Steroids | 1979 | https://conductscience.org/library/papers/442131 | PubMed |
| 4 | 6169181 | Binding of dihydrotestosterone, R 1881 and R 5020 in cytosols from normal, benign hypertrophic and cancerous human prostates. | Urol Int | 1981 | https://conductscience.org/library/papers/6169181 | PubMed |
| 5 | 6022476 | Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group. | Surg Gynecol Obstet | 1967 | https://conductscience.org/library/papers/6022476 | PubMed |
| 6 | 6122893 | Sustained suppression of testosterone production by the luteinising-hormone releasing-hormone agonist buserelin in patients with advanced prostate carcinoma. A new therapeutic approach? | Lancet | 1982 | https://conductscience.org/library/papers/6122893 | PubMed |
| 7 | 7388787 | Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma. | Cancer Res | 1980 | https://conductscience.org/library/papers/7388787 | PubMed |
| 8 | 363037 | Gonadotrophin releasing hormone analogues. | Ann Clin Res | 1978 | https://conductscience.org/library/papers/363037 | PubMed |
| 9 | 6216468 | Steroid receptors and hormone responsiveness of human prostatic carcinoma. | Prostate | 1982 | https://conductscience.org/library/papers/6216468 | PubMed |
| 10 | 6461861 | Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6461861 | PubMed |
| 11 | 4130214 | Steroids of adrenal origin metabolized by human prostatic tissue both in vivo and in vitro. | J Endocrinol | 1974 | https://conductscience.org/library/papers/4130214 | PubMed |
| 12 | 72758 | Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma. | J Clin Endocrinol Metab | 1977 | https://conductscience.org/library/papers/72758 | PubMed |
| 13 | 6411994 | Suppression of testicular steroidogenesis by the GnRH agonistic analogue Buserelin (HOE-766) in patients with prostatic cancer: studies in relation to dose and route of administration. | J Steroid Biochem | 1983 | https://conductscience.org/library/papers/6411994 | PubMed |
| 15 | 7391080 | The specific binding of estrogens and androgens to the nuclear matrix of sex hormone responsive tissues. | J Biol Chem | 1980 | https://conductscience.org/library/papers/7391080 | PubMed |
| 17 | 88456 | Steroid receptor content in cytosol from normal and hyperplastic human prostates. | J Clin Endocrinol Metab | 1979 | https://conductscience.org/library/papers/88456 | PubMed |
| 18 | 326399 | Androgen receptors in human prostatic tissues: a review. | Cancer Treat Rep | 1977 | https://conductscience.org/library/papers/326399 | PubMed |
| 19 | 76668 | Androgen binding in cytosols and nuclei of human benign hyperplastic prostatic tissue. | J Endocrinol | 1978 | https://conductscience.org/library/papers/76668 | PubMed |
| 20 | 173047 | Scatchard plots: common errors in correction and interpretation. | Steroids | 1975 | https://conductscience.org/library/papers/173047 | PubMed |
| 21 | 7062420 | Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer. | J Urol | 1982 | https://conductscience.org/library/papers/7062420 | PubMed |
| 22 | 6282069 | AXC rat prostatic adenocarcinoma: characterization of cells in culture. | Adv Exp Med Biol | 1981 | https://conductscience.org/library/papers/6282069 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 6242478 | An oriented phase-II trial of D-Trp6-LH-RH in patients with prostatic carcinoma. | Med Oncol Tumor Pharmacother | 1984 | https://conductscience.org/library/papers/6242478 |
Source PubMed
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACP3 | 55 | PubTator's text mining | https://conductscience.org/library/genes/55 | NCBI Gene |
| GNRH1 | 2796 | PubTator's text mining | https://conductscience.org/library/genes/2796 | NCBI Gene |
| PRL | 5617 | PubTator's text mining | https://conductscience.org/library/genes/5617 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6443576
GET https://conductscience.org/api/papers/v1/6443576/references?page=2